Zdrowie i gospodarka · 03/04/2024
FDA Announces Draft Guidance for Oxymetazoline Hydrochloride
The FDA is releasing a draft guidance document outlining product-specific recommendations for the development of oxymetazoline hydrochloride ophthalmic solution, including bioequivalence studies to support ANDA submissions.